Alithea Genomics

Lausanne, Switzerland

Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.

$3.8M raised

Mar 2026

Seed

Biopharma Biotechnology Genetics

Top Investors

Genku VenturesKickfundZürcher Kantonal BankNovalis Biotechnology IncubationTechU Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alithea Genomics

How much funding has Alithea Genomics raised?

Alithea Genomics has raised $3.8M in total funding. The most recent round was Seed. The last funding was announced in March 2026.

Who are Alithea Genomics's investors?

Alithea Genomics's investors include Genku Ventures, Kickfund, Zürcher Kantonal Bank, Novalis Biotechnology Incubation, TechU Ventures.

Where is Alithea Genomics headquartered?

Alithea Genomics is headquartered in Lausanne, Switzerland.

What does Alithea Genomics do?

Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.

What stage is Alithea Genomics at?

Alithea Genomics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 4, 2026.

MLA

"Alithea Genomics — Funding & Investors." VCBacked, March 4, 2026, https://www.vcbacked.co/company/alithea-genomics. Accessed June 30, 2026.

APA

VCBacked. (2026). Alithea Genomics — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/alithea-genomics

Wikipedia (cite web)

{{cite web |title=Alithea Genomics — Funding & Investors |url=https://www.vcbacked.co/company/alithea-genomics |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 4, 2026.

Similar Companies in Biopharma

Mineralys Therapeutics